---
title: "RSLS.US (RSLS.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/RSLS.US/news.md"
symbol: "RSLS.US"
name: "RSLS.US"
parent: "https://longbridge.com/en/quote/RSLS.US.md"
datetime: "2026-03-04T02:32:08.260Z"
locales:
  - [en](https://longbridge.com/en/quote/RSLS.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/RSLS.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/RSLS.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/RSLS.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/RSLS.US/news.md)


# RSLS.US (RSLS.US) — Related News

### [Restart Life Sciences Becomes Revenue Producer With Holy Crap Foods Acquisition](https://longbridge.com/en/news/277213976.md)
*2026-02-27T14:21:05.000Z*
> Restart Life Sciences has acquired Holy Crap Foods Inc., gaining 100% ownership of the functional cereal brand and its a

### [Zydus Lifesciences says successful clinical development of pembrolizumab biosimilar fyb206](https://longbridge.com/en/news/277174349.md)
*2026-02-27T09:35:53.000Z*
> Zydus Lifesciences says successful clinical development of pembrolizumab biosimilar fyb206

### [](https://longbridge.com/en/news/276947884.md)
*2026-02-25T22:02:55.000Z*
> Maravai LifeSciences Holdings shares are trading higher after the company reported better-than-expected Q4 financial res

### [Zydus Lifesciences receives US FDA approval for bosentan tablets, 32 mg](https://longbridge.com/en/news/276229686.md)
*2026-02-18T12:49:00.000Z*
> Zydus Lifesciences receives US FDA approval for bosentan tablets, 32 mg

### [Zydus: From Generics to Innovation Powerhouse](https://longbridge.com/en/news/276109706.md)
*2026-02-17T09:41:00.000Z*
> Zydus Lifesciences has shifted from a generics manufacturer to an innovation-driven pharmaceutical company, focusing on 

### [India's Zydus, US unit settle Mirabegron patent dispute with $120 million payment](https://longbridge.com/en/news/275693014.md)
*2026-02-12T03:12:21.000Z*
> Feb 12 (Reuters) - India’s Zydus LifesciencesS) said on Thursday that it and its U.S. unit have agreed to pay $120 milli

### [Insights Ahead: Edwards Lifesciences's Quarterly Earnings](https://longbridge.com/en/news/275342635.md)
*2026-02-09T16:01:44.000Z*
> Edwards Lifesciences (NYSE:EW) is set to announce its quarterly earnings on February 10, 2026, with analysts estimating 

### [Zydus Lifesciences receives tentative approval from USFDA for dapagliflozin tablets](https://longbridge.com/en/news/274797754.md)
*2026-02-04T10:45:22.000Z*
> Zydus Lifesciences receives tentative approval from USFDA for dapagliflozin tablets

### [Biotech Stocks Facing FDA Decision In February 2026](https://longbridge.com/en/news/273929972.md)
*2026-01-28T03:45:32.000Z*
> The FDA approved 46 novel drugs in 2025, with 70% receiving approval in the U.S. first. As January 2026 ends, attention 

### [Resonetics to Acquire Resolution Medical, Expanding Capabilities in Neuromodulation and Structural Heart Markets | CG Stock News](https://longbridge.com/en/news/273883342.md)
*2026-01-27T11:00:00.000Z*
> Resonetics has signed an agreement to acquire Resolution Medical, enhancing its capabilities in the neuromodulation and